Showing results (451-460 of 513) with videos related to

Sort By:
Pageof 52
The Journal of Experimental Medicine|November 9, 2016
High-dimensional single-cell analysis reveals the immune signature of narcolepsyFelix J Hartmann, Raphaël Bernard-Valnet, Clémence Quériault, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 16, 2006
Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araCS Maier, S Strasser, P Saiko, et al.
Materials (Basel, Switzerland)|February 9, 2018
On the Potential of Bulk Metallic Glasses for Dental Implantology: Case Study on Ti40Zr10Cu36Pd14Alethea Liens, Aurélien Etiemble, Pascaline Rivory, et al.
Cancer Research|February 27, 2023
Polyunsaturated Fatty Acid-Bound α-Fetoprotein Promotes Immune Suppression by Altering Human Dendritic Cell MetabolismPaul V Munson, Juraj Adamik, Felix J Hartmann, et al.
EMBO Molecular Medicine|February 21, 2024
Targeting PI3K/Akt/mTOR signaling in rodent models of PMP22 gene-dosage diseasesDoris Krauter, Daniela Stausberg, Timon J Hartmann, et al.
Immunity|July 16, 2020
An Integrated Multi-omic Single-Cell Atlas of Human B Cell IdentityDavid R Glass, Albert G Tsai, John Paul Oliveria, et al.
The British Journal of Radiology|April 18, 2019
Machine-learning identifies Parkinson's disease patients based on resting-state between-network functional connectivityChristian Rubbert, Christian Mathys, Christiane Jockwitz, et al.
Frontiers in Human Neuroscience|June 15, 2017
Differential Functional Connectivity Alterations of Two Subdivisions within the Right dlPFC in Parkinson's DiseaseJulian Caspers, Christian Mathys, Felix Hoffstaedter, et al.
Human Pathology|April 4, 2000
Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitisF Fogt, S J Urbanski, M E Sanders, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2026
Impact of whole breast irradiation, endocrine therapy or their combination on outcomes of early-stage, luminal A-like, low-risk, breast cancer patients aged 65 years or over: Insights from the EUSOMA databaseCynthia Aristei, Mariano Tomatis, Antonio Ponti, et al.
Pageof 52